Considerations in developing medical countermeasures against chemical ocular toxicity

被引：5

作者：

Yeung, David T. ^{[1
]}

Araj, Houmam ^{[2
]}

Harper, Jill R. ^{[3
]}

Platoff, Gennady E., Jr. ^{[4
]}

机构：

[1] NIAID, Dept Hlth & Human Serv, NIH, 5601 Fishers Lane,1G58, Bethesda, MD 20892 USA

[2] US Dept HHS, NEI, NTH, 6700B Rockledge Dr,Suite 3400, Bethesda, MD 20817 USA

[3] NIAID, US Dept HHS, NIH, 31 Ctr Dr,MSC 2520, Bethesda, MD 20892 USA

[4] US Dept HHS, NIAID, NIH, 5601 Fishers Lane,1G55, Bethesda, MD 20892 USA

来源：

TOXICOLOGY LETTERS | 2020年 / 334卷

关键词：

Ocular toxicity; Medical countermeasures; Chemical threats; CCRP; Vesicants; AGENTS;

D O I：

10.1016/j.toxlet.2020.09.004

中图分类号：

R99 [毒物学（毒理学）];

学科分类号：

100405 ;

摘要：

The Chemical Countermeasures Research Program (CCRP) was established in 2006 by the National Institute of Allergy and Infectious Diseases (NIAID/NIH) on behalf of the National Institutes of Health Office of the Director (NIH OD). It is a trans-NIH initiative to expedite the discovery and early development of medical countermeasures (MCMs) that can reduce mortality and serious morbidity during and after large consequence public health emergency involving the deliberate or accidental large-scale release of highly toxic chemicals (HTCs).

引用

页码：1 / 3

页数：3

共 50 条

[21] Developing Countermeasures against Cloning of Identity Tokens in Legacy Systems
Moravec, Pavel
Krumnikl, Michal
COMPUTER INFORMATION SYSTEMS AND INDUSTRIAL MANAGEMENT (CISIM 2017), 2017, 10244 : 672 - 684
[22] Exposure Considerations for Chemical Prioritization and Toxicity Testing
Cohen, Hubal E.
EPIDEMIOLOGY, 2008, 19 (06) : S100 - S100
[23] Medical countermeasures against henipaviruses: a review and public health perspective
Roman, Raul Gomez
Tornieporth, Nadia
Cherian, Neil George
Shurtleff, Amy C.
Jackson, Maina L'Azou
Yeskey, Debra
Hacker, Adam
Mungai, Eric
Tung Thanh Le
LANCET INFECTIOUS DISEASES, 2022, 22 (01): : E13 - E27
[24] Medical countermeasures against nuclear threats: Radionuclide decorporation agents
Cassatt, David R.
Kaminski, Joseph M.
Hatchett, Richard J.
DiCarlo, Andrea L.
Benjamin, Jessica M.
Maidment, Bert W.
RADIATION RESEARCH, 2008, 170 (04) : 540 - 548
[25] Medical countermeasures against the re-emergence of smallpox virus
Jahrling, PB
BIOLOGICAL THREATS AND TERRORISM, WORKSHOP SUMMARY: ASSESSING THE SCIENCE AND RESPONSE CAPABILITIES, 2002, : 51 - 54
[26] Choice of approaches in developing novel medical countermeasures for nerve agent poisoning
Myhrer, Trond
Aas, Pal
NEUROTOXICOLOGY, 2014, 44 : 27 - 38
[27] MITOCHONDRIAL-TARGETED BIOFUELS AS COUNTERMEASURES AGAINST CHEMICAL THREATS
Piel, Sarah
Janowska, Joanna
Kim, Claire
Saliba, Nahima
Berg, Katherine
Jang, David
Ehinger, Johannes
Karlsson, Michael
Kilbaugh, Todd
CRITICAL CARE MEDICINE, 2020, 48
[28] A MULTIMODEL SCREENING PLATFORM FOR DEVELOPMENT OF COUNTERMEASURES AGAINST CHEMICAL THREATS
Janowska, Joanna
Piel, Sarah
Kim, Claire
Saliba, Nahima
Berg, Katherine
Jang, David
Ehinger, Johannes
Karlsson, Michael
Kilbaugh, Todd
CRITICAL CARE MEDICINE, 2020, 48
[29] General considerations in ocular toxicity risk assessment from the toxicologists' viewpoints
Onodera, Hiroshi
Sasaki, Shoji
Otake, Seiji
Tomohiro, Masayuki
Shibuya, Kazumoto
Nomura, Mamoru
JOURNAL OF TOXICOLOGICAL SCIENCES, 2015, 40 (03): : 295 - 307
[30] CONSIDERATIONS IN CHRONIC TOXICITY TESTING - CHEMICAL, THE DOSE, THE DESIGN
MUNRO, IC
JOURNAL OF ENVIRONMENTAL PATHOLOGY AND TOXICOLOGY, 1977, 1 (02) : 183 - 197

← 1 2 3 4 5 →